CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Disease activity, pANCA and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis
DOI 10.1055/s-0029-1241332
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Jürgens, R Laubender, F Hartl, M Weidinger, J Wagner, J Seiderer, F Beigel, J Glas, B Göke, T Ochsenkühn, S Brand
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe09/2009
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: We analysed efficacy and predictors of response to anti-TNF-α antibody induction therapy using infliximab (IFX) in patients with moderate-to-severe ulcerative colitis (UC) in a large single center cohort. Methods: A total of 90 IFX-treated UC patients was analysed retrospectively. For evaluation of disease activity, the colitis activity index (CAI) was calculated. Genotyping for UC-associated variants…
Zitieren
Zitierempfehlung
M Jürgens, R Laubender, F Hartl, M Weidinger, J Wagner, J Seiderer, F Beigel, J Glas, B Göke, T Ochsenkühn, S Brand (2009) Disease activity, pANCA and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis. Zeitschrift für Gastroenterologie (09). https://doi.org/10.1055/s-0029-1241332
Mit CareLit weiterarbeiten